Kestra Medical Technologies Ltd (KMTS) Price Prediction & ForecastKMTSForecastKestra Medical Technologies Ltd

Alphio's KMTS stock price prediction model matches the current Kestra Medical Technologies Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $25.41 (-0.89%). The 1-week path is $27.10 (+5.69%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Kestra Medical Technologies (KMTS) is currently not a strong buy due to its low RSI of 23.147, indicating oversold conditions, and a recent 5-day price drop of 5.00%. However, the company has shown significant revenue growth, with Q2 2026 revenue at $22,565,000, a 63% year-over-year increase in prescription volume, and a positive analyst outlook with a price target of $30 from JPMorgan. The main risk is its negative net income, which was -$38,835,000 in Q4 2026, indicating ongoing financial challenges.

Kestra Medical Technologies Ltd (KMTS) last closed at $25.64, losing -0.66%. These facts feed the 1-day and 1-week KMTS price prediction above.